Ticker name:SCLX Scilex Holding Co
Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.
- CEO: Henry H. Ji
- IPO: Mar 05, 2021
- Website:...lexholding.com (open a new tab)
Market Cap 51M
Last close 6.01$
Key metrics
Largest 17 companies In Drug Manufacturers - General
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & Co | 960B | 1018.87$ | |
| 2 | AZN | ASTRAZENECA PLC | 581B | 187.46$ | |
| 3 | JNJ | JOHNSON & JOHNSON | 552B | 229.32$ | |
| 4 | ABBV | AbbVie Inc. | 375B | 212.3$ | |
| 5 | NVS | NOVARTIS AG | 287B | 150.45$ | |
| 6 | MRK | Merck & Co., Inc. | 279B | 113$ | |
| 7 | AMGN | AMGEN INC | 179B | 331.57$ | |
| 8 | GILD | GILEAD SCIENCES, INC. | 162B | 130.69$ | |
| 9 | PFE | PFIZER INC | 147B | 25.79$ | |
| 10 | BMY | BRISTOL MYERS SQUIBB CO | 120B | 58.54$ | |
| 11 | SNY | Sanofi | 109B | 44.67$ | |
| 12 | BIIB | BIOGEN INC. | 28B | 187.8$ | |
| 13 | OGN | Organon & Co. | 3.5B | 13.46$ | |
| 14 | CTOR | CITIUS ONCOLOGY, INC. | 77M | 0.826$ | |
| 15 | SRXH | SRx Health Solutions, Inc. | 69M | 0.1175$ | |
| 16 | SCLX | Scilex Holding Co | 51M | 6.01$ | |
| 17 | MIRA | MIRA PHARMACEUTICALS, INC. | 41M | 0.9676$ |